Skip to content

Effects of beta-blockers on hemodynamics and microcirculation in patients with septic shock

Effects of beta-blockers on hemodynamics and microcirculation in patients with septic shock

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049558
Enrollment
Unknown
Registered
2021-08-02
Start date
2021-03-01
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic shock

Interventions

Treatment group and :Esmolol pump

Sponsors

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 85 years old; 2. diagnosis of septic shock within 24 hours. The 2016 SSC guidelines for the diagnosis of septic shock; 3. the treatment of sedation and analgesia was satisfactory, but the heart rate was more than 95 beats / min; 4. indwelling floating ductus arteriosus and invasive ductus arteriosus; 5. early adequate fluid resuscitation, that is, patients with passive leg lift test (passivelegraise, PLR) increased cardiac output by less than 10% after fluid resuscitation; 6. sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) pregnancy; (2) II, III degree atrioventricular block; (3) have a history of severe asthma; (4) severe chronic obstructive pulmonary disease; (5) obvious cardiac insufficiency, which needs to be maintained by positive inotropic drugs (that is, cardiac index [CI] 18mmHg); severe valvular heart disease; acute coronary syndrome; (6) chronic renal insufficiency and liver insufficiency.

Design outcomes

Primary

MeasureTime frame
Hemodynamic indicators;oxygen metabolism indicators;inflammatory response indicators;changes in sublingual microcirculation;cardiac function;

Countries

China

Contacts

Public ContactSen LU

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital

lu.sen.cool@163.com+86 13688170025

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026